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Aim: We have previously found that chronic endothelin-1 (ET-1) infusion in Sprague–Dawley rats increases
glomerular permeability to albumin (Palb) as assessed in vitro independent of blood pressure with no ob-
served albuminuria. In this study, we hypothesized that ET-1 increases glomerular albumin ﬁltration with ac-
companied increase in albumin uptake via the proximal tubule, which masks the expected increase in urinary
albumin excretion.
Main methods: Nonfasting Munich-Wistar Fromter rats were surgically prepared for in vivo imaging (n=6).
Rats were placed on the microscope stage with the exposed kidney placed in a cover slip-bottomed dish
bathed in warm isotonic saline. Rats were then injected i.v. with rat serum albumin conjugated to Texas
Red that was observed to enter capillary loops of superﬁcial glomeruli, move into Bowman's space, bind to
the proximal tubular cell brush border and reabsorbed across the apical membrane. Glomerular sieving coef-
ﬁcient (GSC) was calculated as the ratio of conjugated albumin within the glomerular capillary versus that in
Bowman's space. Rats were again studied after 2 weeks of chronic ET-1 (2 pmol/kg/min; i.v. osmotic min-
ipump).
Key ﬁndings: Glomerular sieving coefﬁcient was signiﬁcantly increased in rats following chronic ET-1 infusion
(0.025±0.005 vs. 0.017±0.003, pb0.05). Mean ﬂuorescence intensity for conjugated albumin within prox-
imal tubules was increased by ET-1 infusion: 118.40±6.34 vs. 74.27±4.45 pixel intensity (pb0.01).
Signiﬁcance: These data provide in vivo evidence that ET-1 directly increases glomerular permeability to al-
bumin and that albuminuria is prevented by increased PT albumin uptake in the rat.© 2012 Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Proteinuria and albuminuria represent early signs of glomerular in-
jury, and their presence predicts not only an elevated risk for nephrop-
athy, but also cardiovascular disease in general (Perkins et al., 2007).
The mechanistic pathways of albuminuria in chronic kidney disease
(CKD) have not been resolved. Concerning the proteinuric role of ET-1,
a recent phase III clinical trial in patients with diabetic nephropathy
demonstrated that avosentan, a modestly selective endothelin-A (ETA)
antagonist, decreased urinary albumin excretion rate after 12 weeks of
treatment (Wenzel et al., 2009). These studies have been conﬁrmed
with a more selective ETA blocker (Kohan et al., 2011). Furthermore,
most of the subjects in these studies were already receiving treatmentedicine, Department of Medi-
0912-2500, USA. Tel.: +1 706
ollock).
-NC-ND license.with angiotensin receptor blockers and/or angiotensin converting en-
zyme inhibitors indicating an independent anti-proteinuric effect of
endothelin receptor antagonism. Despite these observations in both an-
imals andhumans, little is known about the speciﬁcmechanisms of ET-1
action in CKDs and many of the beneﬁcial effects of ET antagonists have
not been distinguished from their blood pressure lowering effect.
We have recently reported that a non-pressor 2-week infusion of
ET-1 increases glomerular permeability to albumin (Palb), however,
this dose does not induce proteinuria or albuminuria in normal
Sprague–Dawley rats (Saleh et al., 2010a). The absence of albumin-
uria suggests that the changes in permeability determined in isolated
glomeruli are not sufﬁcient to translate into measurable albuminuria.
Recent studies have renewed interest in the role of proximal tubular
uptake of albumin in protecting against albuminuria (Russo et al.,
2007). In addition, changes in Palb on the order of magnitude that we
observed in the chronic ET-1 model, 0.4 (Saleh et al., 2010a), are much
less than those observed in rats displaying overt proteinuria associated
with hyperglycemia, >0.8 (Fabris et al., 2001; Saleh et al., 2010b, 2011).
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ability typically occurs prior to the development of overt proteinuria
(Melnick et al., 1981; Bjorn et al., 1995; Sharma et al., 2002; Doublier
et al., 2003).
The current study was designed to 1) conﬁrmwhether chronic ET-1
causes glomerular albumin leakage in an intact kidney, and 2) whether
proximal tubular re-uptake of albumin could account for a lack of pro-
teinuria following chronic ET-1 infusion in the rat. Our approachused in-
travital 2-photonmicroscopy to visualize glomerular permeability in vivo.
Although the clinical relevance of proteinuria (especially albuminuria)
has been well documented, the quantitative and mechanistic role of
each “barrier” component, including the proximal tubule, in albuminuria
remains an area of considerable excitement and debate (Molitoris, 2010).
Over the past 5 years, the long-standing controversy regarding the quan-
titative role of the proximal tubule in the development of albuminuria has
reachednewheights,with supporting evidence coming frommanydiffer-
ent genetic,molecular, and technical approaches. The use of two-photon
microscopy offers a unique approach to improving the understand-
ing of the roles of glomerular ﬁltration barrier and proximal tubule
in albumin ﬁltration and reabsorption. It allows for direct visualiza-
tion and quantiﬁcation of the glomerular ﬁltration and its associated
S1 proximal tubule segment in Munich Wistar rats with surface glo-
meruli. It also permits quantiﬁcation and relating of changes in
structure and function longitudinally over the course of a disease
process within the same glomerulus, and the corresponding S1 prox-
imal tubule segment. Because the ﬁnal composition of albumin in the
urine is affected by both glomerular ﬁltration and proximal tubule
reabsorption, both processes must be considered (Sandoval et al.,
2012). Our hypothesis predicts that chronic ET-1 increases glomeru-
lar albumin ﬁltration with an accompanied increase in albumin up-




All animal studieswere conducted in compliancewith the American
Physiological Society guidelineswith all protocols and procedures being
reviewed and approved by the Indiana University School of Medicine
Institutional Animal Care and Use Committee. Male Munich-Wistar
rats 200 to 250 g (Simonsen Laboratories, Gilroy, CA) were used in
this study. To facilitate ET-1 or vehicle infusion, rats were anesthetized
with sodium pentobarbital 50 mg/kg, i.p. (Ovation Pharmaceutical,
Deerﬁeld, IL) and a catheter (PE-90) was placed in the jugular vein
and then tunneled subcutaneously to an osmotic minipump (model
2ML2; Alza Scientiﬁc, Palo Atlo, CA) placed subcutaneously at the dor-
sum of the neck. The minipump contained ET-1 (American Peptide
Inc., CA) dissolved in 0.9% NaCl infused at a rate of 2 pmol/kg/min for
a period of 14 days (Saleh et al., 2010a). Only one group of rats was
studied (n=6 rats) which glomerular sieving coefﬁcient and ﬂuores-
cent albumin proximal reuptakewere evaluated before starting ET-1 in-
fusion and after 2 weeks of the continuous infusion of ET-1.
Animal preparation for imaging
Nonfasting Munich Wistar Fromter rats were anesthetized with
50 mg/kg; i.p. sodiumpentobarbital (Ovation Pharmaceutical, Deerﬁeld,
IL). First a catheter was inserted in the femoral vein to enable the deliv-
ery of ﬂuorescent conjugated albumin. To expose the kidney for intravi-
tal imaging an incisionwasmade on the left ﬂank. The ratwas placed on
themicroscope stage with the exposed kidney in contact with the inner
surface of 50-mm glass-bottom dish (Willco Wells BV, Netherlands).
Animals were covered by a water-circulating warming blanket in
order to stabilize the temperature during imaging, In addition, the
microscope stage was warmed using 2 ReptiTherm heating pads (ZooMed Laboratories, San Luis Obispo, CA) one under the upper torso/
head and one under the lower abdomen. The temperature of the animal
was maintained between 36.5 and 37.5 °C. The ×60 water immersion
objective (Nikon PlanApo, NA 1.2)was heated using anobjective heater
(Warner Instruments, Hamden, CT). The mean arterial blood pressure
was from 80 to 112 mmHg as measured via a femoral arterial line
using Lab Chart 6 (AD Instruments, Colorado Springs, CO).
Two-photon microscopy
Unless speciﬁed otherwise, two-photon microscopy was conducted
on the Bio-Rad MRC 1024 confocal/two-photon microscope as de-
scribed previously (Dunn et al., 2002; Yu et al., 2007). The illumination
source was a tunable Tsunami Ti:Sapphire laser from Spectra-physics
(Mountain View, CA). The microscope was an inverted Nikon Eclipse
TE200. The band pass ﬁlters used for the red and green channels were
605/90 and 525/50, respectively. The excitation wavelength was set at
800 nm for all experiments. The anesthetized rat was placed on the mi-
croscope stage with the exposed kidney in direct contact with the cover
glass (see Animal preparation for imaging). A 60× Nikon Plan Apo water
immersion objective (NA 1.2) was used for imaging. All images were
collected at a constant pixel dwell time, which yielded a 1.1-s frame
time for the frame size of 512×512. All images for a given study were
collected at approximately the same focal plane at a depth of approxi-
mately 10–20 μm.
Proteins and probes
Rat serum albumin (Fraction V; Sigma-Aldrich) was conjugated to
Texas Red Sulfonyl Chloride (Invitrogen, Carlsbad, CA) to yield a stoi-
chiometric ratio of 4:1 moles dye:albumin, according to the man-
ufacturer's instructions for amine-reactive probes as previously
reported (Russo et al., 2007).
Glomerular sieving coefﬁcient (GSC) determination
Images were analyzed using MetaMorph v.7.1 (Molecular Devices,
Downingtown, PA), and calculations were done on a Microsoft Excel
spreadsheet. The ﬂuorescence intensity in the plasma was recorded
in a capillary loop, which had the brightest ﬂuorescence in the ﬁeld.
Plasma ﬂuorescence was measured at the outer margins of the capil-
lary lumen, a red blood cell free zone. We selected 3 areas in the uri-
nary space of Bowman's capsule where there were no blood vessels
and where ﬂuorescence intensity was minimal. The average of the 3
areas was calculated. We recorded the number of pixels (area) and
average ﬂuorescence intensities. Calculations of GSCs were based on
average intensity values after subtracting background readings for
plasma and Bowman's space.
Albumin proximal reuptake measurement
Still frames from two-photon movies at 45 min post injection taken
with a 60× water immersion lens with a 1.2 numerical aperture were
captured. Mean pixel intensities were generated following background
subtraction, thresholding of the endosomal pool and quantitative anal-
ysis on ten random ﬁelds per rat, as previously reported (Sandoval and
Molitoris, 2008).
Statistical analysis
All data are presented as mean±SEM. Data was compared using
paired Student's t-test. Differences were considered statistically sig-
niﬁcant with pb0.05. Analysis was performed using GraphPad Prism
Version 5.0 software (GraphPad Software Inc, La Jolla, CA).
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GSC was calculated as the intensity of ﬂuorescent albumin in
Bowman's space divided by the intensity of ﬂuorescent albumin in glo-
merular capillaries. The background intensity for all locations was sub-
tracted prior to calculatingGSC. As shown in Fig. 1, GSCwas signiﬁcantly
increased in rats following chronic ET-1 infusion (0.025±0.005 vs.
0.017±0.003, pb0.05). Intensity of the ﬂuorescent signal was also
quantiﬁed for proximal tubular re-uptake of albumin by measurement
of the ﬂuorescence intensity within the S1 segment. As depicted in
Fig. 2, mean ﬂuorescence intensity for conjugated albumin with Texas
Red in proximal tubules was increased by ET-1 infusion: 118.4±6.3
vs. 74.3±4.4 pixel intensity (pb0.01).
Discussion
The current study provides mechanistic insight into our recent ob-
servations that chronic infusion of exogenous ET-1 increases glomer-
ular permeability to albumin, but has no effect on proteinuria. The
explanation for these apparent contradictory ﬁndings appear to be
the result of a limited, yet signiﬁcant increase in glomerular perme-
ability to albumin while the proximal tubules have the capacity to
take up the additional ﬁltered albumin. Thus, our current study sub-
stantiates previous ﬁndings that attribute a greater role to the proximal
tubules in maintaining albumin homeostasis under both physiologic
and pathologic conditions.
Over the past 21 years since ET-1 discovery, a prominent role of ET-1
in CKD has been increasingly established. In various hypertensive ani-
mal models, there is considerable evidence that ET-1 contributes to
renal inﬂammation, cell proliferation, and ﬁbrosis mainly dependent
of its hypertensive effects mediated by the ETA receptor. Furthermore,
a series of studies originating from the Benigni lab (Benigni et al.,
1993; Bruzzi and Benigni, 1996) and more recently, our own (Saleh
et al., 2010a, 2010b, 2011), provide compelling evidence that ET-1 con-
tributes to glomerular podocyte dysfunction as a means of producing
proteinuria. Recent clinical trials also demonstrate that ETA receptor
blockade can produce effective anti-proteinuric effects. However, the
degree to which this occurs independent of blood pressure lowering is
not clear. To address this question, we have used the chronic ET-1 infu-
sionmodel in the ratwhere blood pressure is unchanged, yet there is an
increase in glomerular permeability to albumin (Palb) in isolated glo-
meruli as well as increases in early inﬂammatory markers such as plas-
ma and glomerular monocyte chemoattractant protein-1 (MCP-1) and
soluble intercellular adhesion molecule-1 (sICAM-1) (Saleh et al.,
2010a).Fig. 1. Long term ET-1 treatment increases glomerular albumin permeability. Representative
fore (panel A) and after ET-1 treatment (panel B). Although it is not possible to visually dist
the ﬂuorescence intensity ratio between BS and capillary loop (CL) can be readily determin
tially, and imaged at the same time post injection, plasma levels of albumin following ET-1 tr
sieving coefﬁcients (GSC). Panel C shows average GSC for individual rats taken before and af
after ET-1 infusion, (Bar=15 μm; CL = capillary loops.)We believe that there is a strong relationship between ET-1 and
podocytes either functionally or morphologically. We have found
that ET-1 infusion appeared to cause some detachment of podocytes
and foot process effacement in glomerular tufts relative to saline-
infused control rats via using transmission electron micrographs
suggesting that ET-1 mediates podocyte injury and increases glomer-
ular permeability (Saleh et al., 2010a). We also observed that ET-1 in-
fusion increases nephrin shedding from the glomeruli into the urine
(nephrinuria). Nephrin is a ﬁltration slit protein expressed in podocytes
(Ruotsalainen et al., 1999) and acts as a scaffold of the glomerular ﬁltra-
tion barrier (Garg et al., 2007). Shedding of nephrin into the tubular
ﬂuid is a clear marker of glomerular injury and hence increase in glo-
merular permeability.We found that nephrin excretionwas signiﬁcant-
ly increased in ET-1-infused rats compared to saline-infused control rats
(Saleh et al., 2010a). In addition, we noticed that chronic ETA receptor
activation increased the excretion of nephrin into the urine, again
suggesting that ETA receptors inﬂuence podocyte function and Palb.
Morphologically, others have shown that up-regulation of ET-1 pro-
duction by podocytes is induced by protein overload, resulting in cy-
toskeletal changes associated with foot-process effacement, a
hallmark of chronic glomerular disease (Morigi et al., 2005). More-
over, it has been reported that inhibition of Rho kinases in podocytes,
which are important for the formation of stress ﬁbers, resulted in a
signiﬁcant inhibition of F-actin rearrangement in response to ET-1
(Morigi et al., 2006).
Results of the present study along with those of our previous inves-
tigation demonstrate that ET-1 has important effects on glomerular per-
meability independent of blood pressure. We have also observed that
ETA receptor blockade reduced aluminuria and proteinuria in rats with
diabetes (type 1 model) (Saleh et al., 2010b). Importantly, these previ-
ous studies also included experiments where isolated glomeruli were
incubated with ETA receptor antagonists ex vivo, and we were able to
observe reductions in glomerular albumin permeability. These experi-
ments also provide further evidence for actions of ET-1 within the
glomerulus independent of blood pressure lowering. Guo et al. dem-
onstrated that ablation of as few as 20% of podocytes resulted in al-
buminuria that resolved over 1–2 weeks after the re-establishment
of normal podocyte morphology (Guo et al., 2012). They also showed
that immediately after the onset of albuminuria, proximal tubule cells
underwent a transient burst of proliferationwithout evidence of tubular
damage or increased apoptosis, resulting in an increase in total tubular
cell numbers whichmay explain the increased proximal uptake of albu-
min in our study (Guo et al., 2012).
In a model of streptozotocin induced diabetes, Gagliardini and col-
leagues used fractional clearance of graded-size Ficoll molecules toimages of Munich Wistar Fromter glomeruli using 2-photon intravital microscopy be-
inguish relative differences in Bowman's space (BS) albumin content by the naked eye,
ed. Despite having been given an identical amount of Texas Red rat serum albumin ini-
eatment decreased more rapidly and yielded a higher ﬂuorescence ratio, i.e., glomerular
ter chronic ET-1 infusion. For the 6 rats, a total of 28 glomeruli were studied before and
Fig. 2. ET-1 exposure increases albumin reabsorption by proximal tubule (PT) segments in ET-1 treated rats. Representative images of proximal tubule (PT) segments from Munich
Wistar Fromter rats observed via 2-photon intravital microscopy before (panel A) and after (panel B) ET-1 treatment. Images taken before ET-1 exposure show some heterogenous
accumulation of ﬁltered albumin in PT segments; with some segments exhibiting decreased accumulation (PT*). In images taken after ET-1 infusion, accumulation of albumin was
seen in a greater percentage of PT segments, with the number of PT segments showing little or no albumin accumulation (although still present) decreasing in number. Average
pixel intensity values for background-subtracted images for individual rats before and after ET-1 treatment in are presented in panel C. (Bar=15 μm.)
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ics. Avosentan, a modestly selective ETA antagonist, had no effect on
the ultraﬁltration coefﬁcient, but was able to prevent podocyte loss
and partially lowered proteinuria and albuminuria. This could be
due to the effect of the ETA receptor antagonist on glomerular hemo-
dynamics as opposed to a direct effect on permselectivity. In addition,
avosentan increased peritubular capillary perfusion, which could en-
hance proximal tubular protein reabsorption (Gagliardini et al.,
2009). While it is possible that ET-1 could have a direct effect to en-
hance proximal tubular uptake of ﬁltered albumin, it appears that
the increased ﬁltered load of albumin is still below the capacity of
the proximal tubule to reabsorb albumin, but this will need to be fur-
ther investigated.
Infusion of ET-1 for longer time periods and/or at higher concen-
trations in the rat could potentially have a more profound impact
on glomerular permeability that could result in signiﬁcant albumin-
uria and/or proteinuria. The level at which glomeruli are exposed to
ET-1 in our model versus models of overt proteinuria is not known.
Future studies will have to provide more detailed characterization
of this model.
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